Archimedes is a European specialty pharmaceutical company with an established commercial organisation in the UK, France, Germany and Ireland and a portfolio of products marketed to specialist prescribers.

Dose Counting Pump and Vial
Archimedes' lead development product is NasalFent, an innovative fentanyl citrate nasal spray, aimed at providing a fast, effective and convenient treatment for breakthrough cancer pain. An international Phase III clinical development programme is approaching completion and the product is targeted for launch in 2010. In April 2009 Archimedes submitted a centralised Marketing Authorisation Application with the European Medicines Evaluation Agency (EMEA) for approval of NasalFent.
We helped Archimedes by establishing an out-sourced supply chain for commercial manufacture:
- Worked with the selected contract manufacturer to plan the facilities build and drug scale-up activities
- Negotiated commercial supply agreements for primary containers and spray pumps (closures)
- Identified, assessed and selected the supplier of custom fill-capping equipment for the primary container and closure
- In conjunction with third-party technical consultants, developed a novel child-resistant secondary container.

Vial Filling and Capping
